Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease

Journal of Parkinson's Disease

Volumn 4, Issue 4, 2014, Pages 617-627

  Rahimi, Fariborz ^a,e   Bee, Carina ^a   Duval, Christian ^b   Boissy, Patrick ^c   Edwards, Roderick ^d   Jog, Mandar ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b CENTRE DE RECHERCHE   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

^d UNIVERSITY OF VICTORIA   (Canada)

^e UNIVERSITY OF BONAB   (Iran)

Author keywords

biomedical engineering; follow up studies; kinematics; mobility limitations; Parkinson's disease (PD)

Indexed keywords

AMANTADINE; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; PROFENAMINE; RASAGILINE;

AGED; ARTICLE; BIOPHYSICAL EQUIPMENT; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; ECOLOGICAL WHOLE BODY KINEMATICS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; KINEMATICS; LIFE SPACE QUESTIONNAIRE; LIMITED MOBILITY; MALE; MCGILL PAIN QUESTIONNAIRE; MEDICATION THERAPY MANAGEMENT; MONTREAL COGNITIVE ASSESSMENT; OUTCOME ASSESSMENT; PARKINSON DISEASE; PHONE FITT QUESTIONNAIRE; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; TASK PERFORMANCE;

EID: 84914687632     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-140370     Document Type: Article

References (26)

1. Williams AJ, Peterson DS, &Earhart GM (2013) Gait coordination in Parkinson disease: Effects of step length and cadence manipulations. Gait Posture, 38, 340-344.
2. Gouelle A, Megrot F, Presedo A, Pennecot GF, & Yelnik A (2011) Validity of Functional Ambulation Performance Score for the evaluation of spatiotemporal parameters of children's gait. J Mot Behav, 43, 95-100.
3. Cho C, Kunin M, Kudo K, Osaki Y, Olanow CW, Cohen B, & Raphan T (2010) Frequency-velocity mismatch: A fundamental abnormality in parkinsonian gait. J Neurophysiol, 103, 1478-1489.
4. Delval A, Snijders AH, Weerdesteyn V, Duysens JE, Defebvre L, Giladi N,&Bloem BR (2010) Objective detection of subtle freezing of gait episodes in Parkinson's disease. Mov Disord, 25, 1684-1693.
5. Galna B, Lord S, Daud D, Archibald N, Burn D,&Rochester L (2012)Visual sampling duringwalking in people with Parkinson's disease and the influence of environment and dual-task. Brain Research, 1473, 35-43.
6. Saber-Sheikh K, Bryant EC, Glazzard C, Hamel A, & Lee RYW (2010) Feasibility of using inertial sensors to assess human movement. Manual Therapy, 15, 122-125.
7. Spyers-Ashby JM, Stokes MJ, Bain PG, & Roberts SJ (1999) Classification of normal and pathological tremors using a multidimensional electromagnetic system. Med Eng Physics, 21, 713-723.
8. Wild L, Lima D, Balardin J, Rizzi L, Giacobbo B, Oliveira H, Lima Argimon I, Peyré-Tartaruga L, Rieder CM,&Bromberg E (2013) Characterization of cognitive and motor perfor mance during dual-tasking in healthy older adults and patients with Parkinson's disease. J Neurol, 260, 580-589.
9. Roemmich RT, Field AM, Elrod JM, Stegemöller EL, Okun MS,&Hass CJ (2013) Interlimb coordination is impaired duringwalking in persons with Parkinson's disease. Clin Biomech (Bristol, Avon), 28, 93-97.
10. Manson AJ, Brown P, O'Sullivan JD, Asselman P, Buckwell D, & Lees AJ (2000) An ambulatory dyskinesia monitor. J Neurol Neurosurg Psychiatry, 68, 196-201.
11. Hoff JI, van der Meer V, & van Hilten JJ (2004) Accuracy of objective ambulatory accelerometry in detecting motor complications in patients with Parkinson disease. Clin Neuropharmacol, 27, 53-57.
12. Schepers HM, Roetenberg D, & Veltink PH (2010) Ambulatory human motion tracking by fusion of inertial and magnetic sensing with adaptive actuation. Med Biol Eng Comput, 48, 27-37.
13. Rahimi F, Duval C, Jog M, Bee C, South A, Edwards R, & Boissy P (2011) Capturing whole-body mobility of patients with Parkinson disease using inertial motion sensors: Expected challenges and rewards. Conf Proc IEEE Eng Med Biol Soc, 2011, 5833-5888.
14. Carignan B, Daneault J-F, & Duval C (2011) Assessing druginduced dyskinesia in the clinic, the laboratory and the natural environment of patients. J Parkinsons Dis, 1, 329-337.
15. Esselink RA, de Bie RM, de Haan RJ, Lenders MW, Nijssen PC, Staal MJ, Smeding HM, Schuurman PR, Bosch DA, & Speelman JD (2004) Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial. Neurology, 62, 201-207.
16. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, & Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord, 25, 2649-2653.
17. Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB,&Weintraub D(2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73, 1738-1745.
18. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, & Tong K (1997) Validity of the McGill Quality of Life Questionnaire in the palliative care setting: A multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med, 11, 3-20.
19. Gill DP, Jones GR, Zou GY, & Speechley M (2008) The Phone-FITT: A brief physical activity interview for older adults. J Aging Phys Act, 16, 292-315.
20. Stalvey BT, Owsley C, Sloane ME, & Ball K (1999) The Life Space Questionnaire: A measure of the extent of mobility of older adults. J Appl Gerontol, 18, 460-478.
21. Hauser RA, & Auinger P (2011) Determination of minimal clinically important change in early and advanced Parkinson's disease. Mov Disord, 26, 813-818.
22. Tibshirani R (1994) Regression shrinkage and selection via the lasso. J R Stat Soc Ser B, 58, 267-288.
23. Mann RK, Edwards R, Zhou J, Fenney A, Jog M, & Duval C (2012) Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia. Exp Brain Res 218, 639-654.
24. Gour J, Edwards R, Lemieux S, Ghassemi M, Jog M,&Duval C (2007) Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease. Brain Res Bull 74, 66-74.
25. Fenney A, Jog MS, & Duval C (2008) Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea. Clin Neurol Neurosurg, 110, 160-167.
26. Daneault JF, Carignan B, Sadikot AF, Panisset M, & Duval C (2013) Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia BMC Med, 11, 76.